OTC · Financial Statements

ImmuPharma plc (IMMPF) Financial Statements

$0.09 OTC: IMMPF Market Cap $28.34M

Full income statement, balance sheet, and cash flow statement for ImmuPharma plc (IMMPF), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.80
EV / EBITDA	-7.08
FCF Yield	-12.92%
Quick Ratio	1.52
Interest Coverage	-2.30
Return 1Y	—
Return 3Y	—
Return 5Y	—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

IMMPF Overview IMMPF Dividend Run Stock Screener